GPX-200

N/A

Report date: 2022/02/11 13:20:26
NME

Base Information

Drug NameGPX-200
Drug Alias NameGPX-200
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGem Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGem Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A